All News

The increased risk may be due to changes in the brain’s dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia.

High blood pressure may be an accelerant of cognitive decline in middle-aged and older adults, according to research published in Hypertension.

A new study published in Experimental Physiology suggests that taking temperature readings of a person’s fingertip and eye would give a significantly better and more reliable reading and help identify those with fever compared to a full body scan.

The drop is the largest single-year decline in life expectancy in 40 years and is the lowest estimate since 2003.

Pharmacists can learn how to adequately inform patients about therapeutic options that are available as a method to improve access to care.

Narsoplimab is an investigational, fully human IgG4 monoclonal antibody was designed to bind to mannan-binding lectin-associated serine protease-2

Limitations of the study included the sample size of the participants and a gender imbalance across the groups, with more women randomized to bimagrumab and more men to the placebo.

A recent study sought to investigate the attitudes of women with a history of injection—both medical and substance use—toward long-acting injectable HIV therapies.

First of its kind therapy combines 2 existing medications to battling debilitating methamphetamine use disorder.

New treatment approach is designed to treat retracted blood clots, which form over extended periods of time and are especially dense.

The statement said lactating women should discuss the risks and benefits of the COVID-19 vaccine with their health care provider.

Regular exercise and sufficient sleep can help strengthen the response to the COVID-19 vaccine.

This conditional approval is the first under the 2018 reauthorization of the FDA’s Animal Drug User Fee Act program, through which Congress granted the FDA a limited expansion of the conditional approval pathway for certain new animal drugs.

A minimally invasive, targeted treatment option, ImPACT is also under evaluation in patients with other localized tumors, such as urothelial cancer, esophageal cancer, lung cancer, and pancreatic cancer.

Multiple large-scale studies have suggested that menopause is a sex-specific risk factor for cognitive dysfunction independent of aging and other menopause symptoms, such as depression, anxiety, and hot flashes.

Macrophages could be critical treatment targets because they could be infected by SARS-CoV-2 and can contribute to spreading the infection through the lung.

The FDA approved Enhertu in January 2020 for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.

The right balance of stem cell dose, cell type, and timing of antiretroviral therapy (ART) could potentially lead to a spontaneous cure of HIV, according to the study authors.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Daratumumab and hyaluronidase-fihj, a subcutaneous formulation of daratumumab, is the first FDA-approved treatment for patients with AL amyloidosis.

A new study suggests abnormal sleep architecture can be a predictor of stress.

A survey found that the majority of oncologists did not feel like they could perform their duties as well as they could prior to the COVID-19 pandemic.

The study authors note that COVID-19 disease processes could predispose patients to a higher burden of acute brain dysfunction.

B.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.

The changes, finalized today, are generally effective for the 2022 plan year and will potentially lower enrollee cost sharing on some of the most expensive prescription drugs.

Crizotinib is the first biomarker-driven therapy for relapsed or refractory anaplastic large cell lymphoma in children and young adults.

Recent surveys indicate that the proportion of the US population willing to be vaccinated for COVID-19 has fluctuated from 72% in May to 51% in September 2020.

The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.

In a statement by the APhA, Scott J. Knoer, executive vice president and CEO of APhA, noted the association’s support for this first step by the Biden administration on the road to recovery from the pandemic.

Participants with severe withdrawal symptoms were more likely to be younger, longtime and frequent users of cannabis, and to have worse mental health.